Themicrocirculation: A key player in obesity-associated cardiovascular disease

Cardiovascular Research

Volumn 113, Issue 9, 2017, Pages 1035-1045

  Sorop, Oana ^a   Olver, T Dylan ^b   Van DeWouw, Jens ^a   Heinonen, Ilkka ^c   Van Duin, Richard W ^a,d   Duncker, Dirk J ^a   Merkus, Daphne ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MISSOURI   (United States)

^c UNIVERSITY OF TURKU   (Finland)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Adipose tissue; Endothelial dysfunction; Insulin resistance; Microvascular disease; Obesity

Indexed keywords

ADIPOSE TISSUE; ANIMAL; BRAIN; BRAIN CIRCULATION; CARDIOVASCULAR DISEASE; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; ENERGY METABOLISM; HEMODYNAMICS; HUMAN; KIDNEY; KIDNEY CIRCULATION; LUNG; LUNG CIRCULATION; METABOLISM; MICROCIRCULATION; MICROVASCULATURE; OBESITY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; VASCULARIZATION;

ADIPOSE TISSUE; ADIPOSITY; ANIMALS; BRAIN; CARDIOVASCULAR DISEASES; CEREBROVASCULAR CIRCULATION; CORONARY CIRCULATION; CORONARY VESSELS; ENERGY METABOLISM; HEMODYNAMICS; HUMANS; KIDNEY; LUNG; MICROCIRCULATION; MICROVESSELS; MUSCLE, SKELETAL; OBESITY; PULMONARY CIRCULATION; RENAL CIRCULATION; SIGNAL TRANSDUCTION;

EID: 85025428514     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvx093     Document Type: Review

References (129)

1. Kim SH, Despres JP, Koh KK. Obesity and cardiovascular disease: Friend or foe?. Eur Heart J 2016;37:3560-3568.
2. Bagi Z, Feher A, Cassuto J. Microvascular responsiveness in obesity: Implications for therapeutic intervention. Br J Pharmacol 2012;165:544-560.
3. Berwick ZC, Dick GM, Tune JD. Heart of the matter: Coronary dysfunction in metabolic syndrome. J Mol Cell Cardiol 2012;52:848-856.
4. Koller A, Balasko M, Bagi Z. Endothelial regulation of coronary microcirculation in health and cardiometabolic diseases. Intern Emerg Med 2013;8(Suppl 1):S51-S54.
5. Vogel RA, Corretti MC, Plotnick GD. Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cardiol 1997;79:350-354.
6. Hozumi T, Eisenberg M, Sugioka K, Kokkirala AR, Watanabe H, Teragaki M, Yoshikawa J, Homma S. Change in coronary flow reserve on transthoracic Doppler echocardiography after a single high-fat meal in young healthy men. Ann Intern Med 2002;136:523-528.
7. Scalia R. The microcirculation in adipose tissue inflammation. Rev Endocr Metab Disord 2013;14:69-76.
8. Muris DM, Houben AJ, Schram MT, Stehouwer CD. Microvascular dysfunction: An emerging pathway in the pathogenesis of obesity-related insulin resistance. Rev Endocr Metab Disord 2013;14:29-38.
9. Eringa EC, Bakker W, van Hinsbergh VW. Paracrine regulation of vascular tone, inflammation and insulin sensitivity by perivascular adipose tissue. Vascul Pharmacol 2012;56:204-209.
10. Laughlin MH, Davis MJ, Secher NH, van Lieshout JJ, Arce-Esquivel AA, Simmons GH, Bender SB, Padilla J, Bache RJ, Merkus D, Duncker DJ. Peripheral circulation. Compr Physiol 2012;2:321-447.
11. Schinzari F, Tesauro M, Cardillo C. Endothelial and perivascular adipose tissue abnormalities in obesity-related vascular dysfunction: novel targets for treatment. J Cardiovasc Pharmacol 2017; doi: 10.1097/FJC.0000000000000469.
12. Vanhoutte PM, Shimokawa H, Feletou M, Tang EH. Endothelial dysfunction and vascular disease: A 30th anniversary update. Acta Physiol 2017;219:22-96.
13. Zhou Z, Merkus D, Cheng C, Duckers HJ, Jan Danser AH, Duncker DJ. Uridine adenosine tetraphosphate is a novel vasodilator in the coronary microcirculation which acts through purinergic P1 but not P2 receptors. Pharmacol Res 2013;67:10-17.
14. Cocks M, Shaw CS, Shepherd SO, Fisher JP, Ranasinghe A, Barker TA, Wagenmakers AJ. Sprint interval and moderate-intensity continuous training have equal benefits on aerobic capacity, insulin sensitivity, muscle capillarisation and endothelial eNOS/ NAD(P)Hoxidase protein ratio in obese men. J Physiol 2016;594:2307-2321.
15. Chadderdon SM, Belcik JT, Bader L, Kievit P, Grove KL, Lindner JR. Vasoconstrictor eicosanoids and impaired microvascular function in inactive and insulin-resistant primates. Int J Obes 2016;40:1600-1603.
16. Meijer RI, Serne EH, Korkmaz HI, van der Peet DL, de Boer MP, Niessen HW, van Hinsbergh VW, Yudkin JS, Smulders YM, Eringa EC. Insulin-induced changes in skeletal muscle microvascular perfusion are dependent upon perivascular adipose tissue in women. Diabetologia 2015;58:1907-1915.
17. Yudkin JS, Eringa E, Stehouwer CD. "Vasocrine" signalling from perivascular fat: A mechanism linking insulin resistance to vascular disease. Lancet 2005;365:1817-1820.
18. Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 2013;62:263-271.
19. Brown WR, Moody DM, Thore CR, Challa VR, Anstrom JA. Vascular dementia in leukoaraiosis may be a consequence of capillary loss not only in the lesions, but in normal-appearing white matter and cortex as well. J Neurol Sci 2007;257:62-66.
20. Kalaria RN. Cerebrovascular disease and mechanisms of cognitive impairment: Evidence from clinicopathological studies in humans. Stroke 2012;43:2526-2534.
21. Teta D. Adipokines as uremic toxins. J Ren Nutr 2012;22:81-85.
22. Pellegrinelli V, Carobbio S, Vidal-Puig A. Adipose tissue plasticity: How fat depots respond differently to pathophysiological cues. Diabetologia 2016;59:1075-1088.
23. Trayhurn P, Alomar SY. Oxygen deprivation and the cellular response to hypoxia in adipocytes: Perspectives on white and brown adipose tissues in obesity. Front Endocrinol 2015;6:19.
24. Karpe F, Fielding BA, Ilic V, Macdonald IA, Summers LK, Frayn KN. Impaired postprandial adipose tissue blood flow response is related to aspects of insulin sensitivity. Diabetes 2002;51:2467-2473.
25. Sansbury BE, Cummins TD, Tang Y, Hellmann J, Holden CR, Harbeson MA, Chen Y, Patel RP, Spite M, Bhatnagar A, Hill BG. Overexpression of endothelial nitric oxide synthase prevents diet-induced obesity and regulates adipocyte phenotype. Circ Res 2012;111:1176-1189.
26. Trayhurn P. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev 2013;93:1-21.
27. Shimizu I, Aprahamian T, Kikuchi R, Shimizu A, Papanicolaou KN, MacLauchlan S, Maruyama S, Walsh K. Vascular rarefaction mediates whitening of brown fat in obesity. J Clin Invest 2014;124:2099-2112.
28. Shimizu I, Walsh K. The whitening of brown fat and its implications for weight management in obesity. Curr Obes Rep 2015;4:224-229.
29. Oh KJ, Lee DS, Kim WK, Han BS, Lee SC, Bae KH. Metabolic adaptation in obesity and type II diabetes: Myokines, adipokines and hepatokines. Int J Mol Sci 2016;18:pii:E8.
30. Gealekman O, Guseva N, Hartigan C, Apotheker S, Gorgoglione M, Gurav K, Tran KV, Straubhaar J, Nicoloro S, Czech MP, Thompson M, Perugini RA, Corvera S. Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity. Circulation 2011;123:186-194.
31. Heinonen IH, Boushel R, Kalliokoski KK. The circulatory and metabolic responses to hypoxia in humans: with special reference to adipose tissue physiology and obesity. Front Endocrinol 2016;7:116.
32. Fuster JJ, Ouchi N, Gokce N, Walsh K. Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease. Circ Res 2016; 118:1786-1807.
33. Limberg JK, Morgan BJ, Schrage WG. Peripheral blood flow regulation in human obesity and metabolic syndrome. Exerc Sport Sci Rev 2016;44:116-122.
34. Limberg JK, De Vita MD, Blain GM, Schrage WG. Muscle blood flow responses to dynamic exercise in young obese humans. J Appl Physiol 2010;108:349-355.
35. Agapitov AV, Correia ML, Sinkey CA, Dopp JM, Haynes WG. Impaired skeletal muscle and skin microcirculatory function in human obesity. J Hypertens 2002; 20:1401-1405.
36. Ribeiro MM, Silva AG, Santos NS, Guazzelle I, Matos LN, Trombetta IC, Halpern A, Negrao CE, Villares SM. Diet and exercise training restore blood pressure and vasodilatory responses during physiological maneuvers in obese children. Circulation 2005;111:1915-1923.
37. Vinet A, Karpoff L, Walther G, Startun A, Obert P, Goret L, Dauzat M, Perez-Martin A. Vascular reactivity at rest and during exercise in middle-aged obese men: Effects of short-term, low-intensity, exercise training. Int J Obes 2011;35:820-828.
38. Karpoff L, Vinet A, Schuster I, Oudot C, Goret L, Dauzat M, Obert P, Perez-Martin A. Abnormal vascular reactivity at rest and exercise in obese boys. Eur J Clin Invest 2009;39:94-102.
39. Bender SB, de Beer VJ, Tharp DL, van Deel ED, Bowles DK, Duncker DJ, Laughlin MH, Merkus D. Reduced contribution of endothelin to the regulation of systemic and pulmonary vascular tone in severe familial hypercholesterolaemia. J Physiol 2014;592:1757-1769.
40. de Beer VJ, Merkus D, Bender SB, Tharp DL, Bowles DK, Duncker DJ, Laughlin MH. Familial hypercholesterolemia impairs exercise-induced systemic vasodilation due to reduced NO bioavailability. J Appl Physiol 2013;115:1767-1776.
41. Limberg JK, Morgan BJ, Sebranek JJ, Proctor LT, Eldridge MW, Schrage WG. Neural control of blood flow during exercise in human metabolic syndrome. Exp Physiol 2014;99:1191-1202.
42. Harrell JW, Johansson RE, Evans TD, Sebranek JJ, Walker BJ, Eldridge MW, Serlin RC, Schrage WG. Preserved microvascular endothelial function in young, obese adults with functional loss of nitric oxide signaling. Front Physiol 2015;6:387.
43. La Favor JD, Dubis GS, Yan H, White JD, Nelson MA, Anderson EJ, Hickner RC. Microvascular endothelial dysfunction in sedentary, obese humans is mediated by NADPH oxidase: Influence of exercise training. Arterioscler Thromb Vasc Biol 2016;36:2412-2420.
44. Limberg JK, Harrell JW, Johansson RE, Eldridge MW, Proctor LT, Sebranek JJ, Schrage WG. Microvascular function in younger adults with obesity and metabolic syndrome: Role of oxidative stress. Am J Physiol Heart Circ Physiol 2013; 305:H1230-H1237.
45. Bender SB, Laughlin MH. Modulation of endothelial cell phenotype by physical activity: Impact on obesity-related endothelial dysfunction. Am J Physiol Heart Circ Physiol 2015;309:H1-H8.
46. Olver TD, Hazell TJ, Hamilton CD, Shoemaker JK, Lemon PW. Impaired superficial femoral artery vasodilation and leg blood flow in young obese women following an oral glucose tolerance test. Appl Physiol Nutr Metab 2012;37:176-183.
47. Hallsten K, Yki-Jarvinen H, Peltoniemi P, Oikonen V, Takala T, Kemppainen J, Laine H, Bergman J, Bolli GB, Knuuti J, Nuutila P. Insulin- and exercise-stimulated skeletal muscle blood flow and glucose uptake in obese men. Obes Res 2003;11:257-265.
48. Limberg JK, Kellawan JM, Harrell JW, Johansson RE, Eldridge MW, Proctor LT, Sebranek JJ, Schrage WG. Exercise-mediated vasodilation in human obesity and metabolic syndrome: Effect of acute ascorbic acid infusion. Am J Physiol Heart Circ Physiol 2014;307:H840-H847.
49. Paltoglou G, Schoina M, Valsamakis G, Salakos N, Avloniti A, Chatzinikolaou A, Margeli A, Skevaki C, Papagianni M, Kanaka-Gantenbein C, Papassotiriou I, Chrousos GP, Fatouros IG, Mastorakos G. Interrelations among the adipocytokines leptin and adiponectin, oxidative stress and aseptic inflammation markers in preand early-pubertal normal-weight and obese boys. Endocrine 2017;55:925-933.
50. Gavin TP, Stallings HW III, Zwetsloot KA, Westerkamp LM, Ryan NA, Moore RA, Pofahl WE, Hickner RC. Lower capillary density but no difference in VEGF expression in obese vs. lean young skeletal muscle in humans. J Appl Physiol 2005; 98:315-321.
51. Frisbee JC, Goodwill AG, Frisbee SJ, Butcher JT, Brock RW, Olfert IM, DeVallance ER, Chantler PD. Distinct temporal phases of microvascular rarefaction in skeletal muscle of obese Zucker rats. Am J Physiol Heart Circ Physiol 2014;307:H1714-17H1728.
52. Heinonen I, Koga S, Kalliokoski KK, Musch TI, Poole DC. Heterogeneity of muscle blood flow and metabolism: Influence of exercise, aging, and disease states. Exerc Sport Sci Rev 2015;43:117-124.
53. Lind L, Lithell H. Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemia. Am Heart J 1993;125:1494-1497.
54. Duncker DJ, Koller A, Merkus D, Canty JM Jr. Regulation of coronary blood flow in health and ischemic heart disease. Prog Cardiovasc Dis 2015;57:409-422.
55. Ahmari SA, Bunch TJ, Modesto K, Stussy V, Dichak A, Seward JB, Pellikka PA, Chandrasekaran K. Impact of individual and cumulative coronary risk factors on coronary flow reserve assessed by dobutamine stress echocardiography. Am J Cardiol 2008;101:1694-1699.
56. Schindler TH, Cardenas J, Prior JO, Facta AD, Kreissl MC, Zhang XL, Sayre J, Dahlbom M, Licinio J, Schelbert HR. Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. J Am Coll Cardiol 2006;47:1188-1195.
57. Hall ME, Brinkley TE, Chughtai H, Morgan TM, Hamilton CA, Jordan JH, Stacey RB, Soots S, Hundley WG. Adiposity is associated with gender-specific reductions in left ventricular myocardial perfusion during dobutamine stress. PLoS One 2016;11:e0146519.
58. Trask AJ, Katz PS, Kelly AP, Galantowicz ML, Cismowski MJ, West TA, Neeb ZP, Berwick ZC, Goodwill AG, Alloosh M, Tune JD, Sturek M, Lucchesi PA. Dynamic micro- and macrovascular remodeling in coronary circulation of obese Ossabaw pigs with metabolic syndrome. J Appl Physiol 2012;113:1128-1140.
59. Bender SB, de Beer VJ, Tharp DL, Bowles DK, Laughlin MH, Merkus D, Duncker DJ. Severe familial hypercholesterolemia impairs the regulation of coronary blood flow and oxygen supply during exercise. Basic Res Cardiol 2016;111:61.
60. Motivala AA, Rose PA, Kim HM, Smith YR, Bartnik C, Brook RD, Muzik O, Duvernoy CS. Cardiovascular risk, obesity, and myocardial blood flow in postmenopausal women. J Nucl Cardiol 2008;15:510-517.
61. Kondo I, Mizushige K, Hirao K, Nozaki S, Tsuji T, Masugata H, Kohno M, Matsuo H. Ultrasonographic assessment of coronary flow reserve and abdominal fat in obesity. Ultrasound Med Biol 2001;27:1199-1205.
62. Tona F, Serra R, Di Ascenzo L, Osto E, Scarda A, Fabris R, Montisci R, Famoso G, Tellatin S, Foletto M, Giovagnoni A, Iliceto S, Vettor R. Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease. Nutr Metab Cardiovasc Dis 2014;24:447-453.
63. Bakkum MJ, Danad I, Romijn MA, Stuijfzand WJ, Leonora RM, Tulevski II, Somsen GA, Lammertsma AA, van Kuijk C, van Rossum AC, Raijmakers PG, Knaapen P. The impact of obesity on the relationship between epicardial adipose tissue, left ventricular mass and coronary microvascular function. Eur J Nucl Med Mol Imaging 2015;42:1562-1573.
64. Wang L, Jerosch-Herold M, Jacobs DR Jr, Shahar E, Folsom AR. Coronary risk factors and myocardial perfusion in asymptomatic adults. The multi-ethnic study of atherosclerosis (MESA). J Am Coll Cardiol 2006;47:565-572.
65. Pries AR, Badimon L, Bugiardini R, Camici PG, Dorobantu M, Duncker DJ, Escaned J, Koller A, Piek JJ, de Wit C. Coronary vascular regulation, remodelling, and collateralization: Mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation. Eur Heart J 2015; 36:3134-3146.
66. Al Suwaidi J, Higano ST, Holmes DR Jr, Lennon R, Lerman A. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol 2001;37:1523-1528.
67. Belin de Chantemele EJ, Stepp DW. Influence of obesity and metabolic dysfunction on the endothelial control in the coronary circulation. J Mol Cell Cardiol 2012;52:840-847.
68. Gao Z, Novick M, Muller MD, Williams RJ, Spilk S, Leuenberger UA, Sinoway LI. Exercise and diet-induced weight loss attenuates oxidative stress related-coronary vasoconstriction in obese adolescents. Eur J Appl Physiol 2013;113:519-528.
69. Feher A, Cassuto J, Szabo A, Patel V, Vinayak Kamath M, Bagi Z. Increased tissue angiotensin-converting enzyme activity impairs bradykinin-induced dilation of coronary arterioles in obesity. Circ J 2013;77:1867-1876.
70. van den Heuvel M, Sorop O, Koopmans SJ, Dekker R, de Vries R, van Beusekom HM, Eringa EC, Duncker DJ, Danser AH, van der Giessen WJ. Coronary microvascular dysfunction in a porcine model of early atherosclerosis and diabetes. Am J Physiol Heart Circ Physiol 2012;302:H85-H94.
71. Sorop O, van den Heuvel M, van Ditzhuijzen NS, de Beer VJ, Heinonen I, van Duin RW, Zhou Z, Koopmans SJ, Merkus D, van der Giessen WJ, Danser AH, Duncker DJ. Coronary microvascular dysfunction after long-term diabetes and hypercholesterolemia. Am J Physiol Heart Circ Physiol 2016;311:H1339-H1351.
72. Owen MK, Noblet JN, Sassoon DJ, Conteh AM, Goodwill AG, Tune JD. Perivascular adipose tissue and coronary vascular disease. Arterioscler Thromb Vasc Biol 2014;34:1643-1649.
73. Campbell DJ, Somaratne JB, Prior DL, Yii M, Kenny JF, Newcomb AE, Kelly DJ, Black MJ. Obesity is associated with lower coronary microvascular density. PLoS One 2013;8:e81798.
74. Gruber C, Kohlstedt K, Loot AE, Fleming I, Kummer W, Muhlfeld C. Stereological characterization of left ventricular cardiomyocytes, capillaries, and innervation in the nondiabetic, obese mouse. Cardiovasc Pathol 2012;21:346-354.
75. Shah SJ, Kitzman DW, Borlaug BA, Heerebeek LV, Zile MR, Kass DA, Paulus WJ. Phenotype-specific treatment of heart failure with preserved ejection fraction. Circulation 2016;134:73-90.
76. Olsen RH, Pedersen LR, Jurs A, Snoer M, Haugaard SB, Prescott E. A randomised trial comparing the effect of exercise training and weight loss on microvascular function in coronary artery disease. Int J Cardiol 2015;185:229-235.
77. Rincon F, Wright CB. Current pathophysiological concepts in cerebral small vessel disease. Front Aging Neurosci 2014;6:1-8.
78. Rodríguez-Flores M, García-García E, Cano-Nigenda CV, Cantu-Brito C. Relationship of obesity and insulin resistance with the cerebrovascular reactivity: A case control study. Cardiovasc Diabetol 2014;13:2-2.
79. Willeumier KC, Taylor DV, Amen DG. Elevated BMI is associated with decreased blood flow in the prefrontal cortex using SPECT imaging in healthy adults. Obesity 2011;19:1095-1097.
80. Last D, Bazelaire CD, Alsop DC, Hu K, Amir M, Cavallerano J, Marquis RP, Novak V. Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care 2007;30:1193-1199.
81. Lavi S, Gaitini D, Milloul V, Jacob G. Impaired cerebral CO2 vasoreactivity: Association with endothelial dysfunction. Am J Physiol Heart Circ Physiol 2006; 291:H1856-H1861.
82. Brooks SD, DeVallance E, D'audiffret AC, Frisbee SJ, Tabone LE, Shrader CD, Frisbee JC, Chantler PD. Metabolic syndrome impairs reactivity and wall mechanics of cerebral resistance arteries in obese Zucker rats. Am J Physiol Heart Circ Physiol 2015;309:H1846-H1859.
83. Cipola MJ, Control of Cerebral Blood Flow. San Rafael, CA: Morgan & Claypool Life Sciences; 2009.
84. Selim M, Jones R, Novak P, Zhao P, Novak V. The effects of body mass index on cerebral blood flow velocity. Clin Auton Res 2008;18:331-338.
85. Katakam PVG, Snipes JA, Steed MM, Busija DW. Insulin-induced generation of reactive oxygen species and uncoupling of nitric oxide synthase underlie the cerebrovascular insulin resistance in obese rats. J Cereb Blood Flow Metab 2012;32:792-804.
86. Meijer RI, Gray S, Aylor K, Barrett EJ. Pathways for insulin access to the brain: The role of the microvascular endothelial cell. Am J Physiol Heart Circ Physiol 2016;311:H1132-H1138.
87. Park K, Yasuda N, Toyonaga S, Yamada SM, Nakabayashi H, Nakasato M, Nakagomi T, Tsubosaki E, Shimizu K. Significant association between leukoaraiosis and metabolic syndrome in healthy subjects. Neurology 2007;69:974-978.
88. Yamashiro K, Tanaka R, Tanaka Y, Miyamoto N, Shimada Y, Ueno Y, Urabe T, Hattori N. Visceral fat accumulation is associated with cerebral small vessel disease. Eur J Neurol 2014;21:667-673.
89. Chantler PD, Shrader CD, Tabone LE, D'audiffret AC, Huseynova K, Brooks SD, Branyan KW, Grogg KA, Frisbee JC. Cerebral cortical microvascular rarefaction in metabolic syndrome is dependent on insulin resistance and loss of nitric oxide bioavailability. Microcirculation 2015;22:435-445.
90. Deutch C, Portik-Dobos V, Smith AD, Ergul A, Dorrance AM. Diet induced obesity causes cerebral vessel remodeling and increases the damage caused by ischemic stroke. Microvasc Res 2009;78:100-106.
91. Stepp DW, Pollock DM, Frisbee JC. Low-flow vascular remodeling in the metabolic syndrome X. Am J Physiol Heart Circ Physiol 2004;286:H964-H970.
92. Bernier M, Wahl D, Ali A, Allard J, Faulkner S, Wnorowski A, Sanghvi M, Moadde R, Alfaras I, Mattison JA, Tarantini S, Tucsek Z, Ungvari Z, Csiszar A, Pearson KJ, de Cabo R. Resveratrol supplementation confers neuroprotection in cortical brain tissue of nonhuman primates fed a high-fat/sucrose diet. Aging 2016;8:899-916.
93. Le DSNT, Pannacciulli N, Chen K, Salbe AD, Hill JO, Wing RR, Reiman EM, Krakoff J. Less activation in the left dorsolateral prefrontal cortex in the reanalysis of the response to a meal in obese than in lean women and its association with successful weight loss. Am J Clin Nutr 2007;86:573-579.
94. Val-Laillet D, Layec S, Guérin S, Meurice P, Malbert C-H. Changes in brain activity after a diet-induced obesity. Obesity 2011;19:749-756.
95. Li W, Prakash R, Chawla D, Du W, Didion SP, Filosa JA, Zhang Q, Brann DW, Lima VV, Tostes RC, Ergul A. Early effects of high-fat diet on neurovascular function and focal ischemic brain injury. Am J Physiol Regul Integr Comp Physiol 2013; 304:R1001-R1008.
96. Weghuber D, Zaknun D, Nasel C, Willforth-Ehringer A, Müller T, Boriss-Riedl M, Widhalm K. Early cerebrovascular disease in a 2-year-old with extreme obesity and complete metabolic syndrome due to feeding of excessively high amounts of energy. Eur J Pediatr 2007;166:37-41.
97. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyren O. Obesity and risk for chronic renal failure. J Am Soc Nephrol 2006;17:1695-1702.
98. Chade AR, Hall JE. Role of the renal microcirculation in progression of chronic kidney injury in obesity. Am J Nephrol 2016;44:354-367.
99. Li Z, Woollard JR, Wang S, Korsmo MJ, Ebrahimi B, Grande JP, Textor SC, Lerman A, Lerman LO. Increased glomerular filtration rate in early metabolic syndrome is associated with renal adiposity and microvascular proliferation. Am J Physiol Renal Physiol 2011;301:F1078-F1087.
100. Ma S, Zhu XY, Eirin A, Woollard JR, Jordan KL, Tang H, Lerman A, Lerman LO. Perirenal fat promotes renal arterial endothelial dysfunction in obese swine through tumor necrosis factor-alpha. J Urol 2016;195:1152-1159.
101. Chade AR, Best PJ, Rodriguez-Porcel M, Herrmann J, Zhu X, Sawamura T, Napoli C, Lerman A, Lerman LO. Endothelin-1 receptor blockade prevents renal injury in experimental hypercholesterolemia. Kidney Int 2003;64:962-969.
102. Chade AR, Krier JD, Galili O, Lerman A, Lerman LO. Role of renal cortical neovascularization in experimental hypercholesterolemia. Hypertension 2007;50:729-736.
103. Chade AR, Krier JD, Textor SC, Lerman A, Lerman LO. Endothelin-a receptor blockade improves renal microvascular architecture and function in experimental hypercholesterolemia. J Am Soc Nephrol 2006;17:3394-3403.
104. Chade AR, Mushin OP, Zhu X, Rodriguez-Porcel M, Grande JP, Textor SC, Lerman A, Lerman LO. Pathways of renal fibrosis and modulation of matrix turnover in experimental hypercholesterolemia. Hypertension 2005;46:772-779.
105. Wilson SH, Chade AR, Feldstein A, Sawamura T, Napoli C, Lerman A, Lerman LO. Lipid-lowering-independent effects of simvastatin on the kidney in experimental hypercholesterolaemia. Nephrol Dial Transplant 2003;18:703-709.
106. Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 2001;12:1211-1217.
107. Foster MC, Hwang SJ, Porter SA, Massaro JM, Hoffmann U, Fox CS. Fatty kidney, hypertension, and chronic kidney disease: The Framingham Heart Study. Hypertension 2011;58:784-790.
108. Chade AR, Bentley MD, Zhu X, Rodriguez-Porcel M, Niemeyer S, Amores-Arriaga B, Napoli C, Ritman EL, Lerman A, Lerman LO. Antioxidant intervention prevents renal neovascularization in hypercholesterolemic pigs. J Am Soc Nephrol 2004; 15:1816-1825.
109. Li L, Zhao Z, Xia J, Xin L, Chen Y, Yang S, Li K. A long-term high-fat/high-sucrose diet promotes kidney lipid deposition and causes apoptosis and glomerular hypertrophy in bama minipigs. PLoS One 2015;10:e0142884.
110. Khairoun M, van den Heuvel M, van den Berg BM, Sorop O, de Boer R, van Ditzhuijzen NS, Bajema IM, Baelde HJ, Zandbergen M, Duncker DJ, Rabelink TJ, Reinders ME, van der Giessen WJ, Rotmans JI. Early systemic microvascular damage in pigs with atherogenic diabetes mellitus coincides with renal angiopoietin dysbalance. PLoS One 2015;10:e0121555.
111. Liu Y, Wang Z, Yin W, Li Q, Cai M, Zhang C, Xiao J, Hou H, Li H, Zu X. Severe insulin resistance and moderate glomerulosclerosis in a minipig model induced by high-fat/high-sucrose/high-cholesterol diet. Exp Anim 2007;56:11-20.
112. Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet 2017;389:1238-1252.
113. Gabbay E, Slotki I, Shavit L. Weighing the evidence: Obesity, metabolic syndrome, and the risk of chronic kidney disease. BMC Nephrol 2015;16:133.
114. Ter Maaten JM, Damman K, Verhaar MC, Paulus WJ, Duncker DJ, Cheng C, van Heerebeek L, Hillege HL, Lam CS, Navis G, Voors AA. Connecting heart failure with preserved ejection fraction and renal dysfunction: The role of endothelial dysfunction and inflammation. Eur J Heart Fail 2016;18:588-598.
115. Mancuso P. Obesity and lung inflammation. J Appl Physiol 2010;108:722-728.
116. Moore GW, Smith RR, Hutchins GM. Pulmonary artery atherosclerosis: Correlation with systemic atherosclerosis and hypertensive pulmonary vascular disease. Arch Pathol Lab Med 1982;106:378-380.
117. Schwenke DC. Comparison of aorta and pulmonary artery: I. Early cholesterol accumulation and relative susceptibility to atheromatous lesions. Circ Res 1997;81: 338-345.
118. Haque AK, Gadre S, Taylor J, Haque SA, Freeman D, Duarte A. Pulmonary and cardiovascular complications of obesity: An autopsy study of 76 obese subjects. Arch Pathol Lab Med 2008;132:1397-1404.
119. Irwin DC, Garat CV, Crossno JT Jr, MacLean PS, Sullivan TM, Erickson PF, Jackman MR, Harral JW, Reusch JE, Klemm DJ. Obesity-related pulmonary arterial hypertension in rats correlates with increased circulating inflammatory cytokines and lipids and with oxidant damage in the arterial wall but not with hypoxia. Pulm Circ 2014;4:638-653.
120. Medoff BD, Okamoto Y, Leyton P, Weng M, Sandall BP, Raher MJ, Kihara S, Bloch KD, Libby P, Luster AD. Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling. Am J Respir Cell Mol Biol 2009;41:397-406.
121. Friedman SE, Andrus BW. Obesity and pulmonary hypertension: A review of pathophysiologic mechanisms. J Obes 2012;2012:505274.
122. Pfister SL, Campbell WB. Reduced pulmonary artery vasoconstriction in methacholine in cholesterol-fed rabbits. Hypertension 1996;27:804-810.
123. Moral-Sanz J, Menendez C, Moreno L, Moreno E, Cogolludo A, Perez-Vizcaino F. Pulmonary arterial dysfunction in insulin resistant obese Zucker rats. Respir Res 2011;12:51.
124. Ahmadi SF, Zahmatkesh G, Ahmadi E, Streja E, Rhee CM, Gillen DL, De Nicola L, Minutolo R, Ricardo AC, Kovesdy CP, Kalantar-Zadeh K. Association of body mass index with clinical outcomes in non-dialysis-dependent chronic kidney disease: A systematic review and meta-analysis. Cardiorenal Med 2015;6:37-49.
125. Jahangir E, De Schutter A, Lavie CJ. The relationship between obesity and coronary artery disease. Transl Res 2014;164:336-344.
126. Lavie CJ, Sharma A, Alpert MA, De Schutter A, Lopez-Jimenez F, Milani RV, Ventura HO. Update on obesity and obesity paradox in heart failure. Prog Cardiovasc Dis 2016;58:393-400.
127. Andersen KK, Olsen TS. The obesity paradox in stroke: Lower mortality and lower risk of readmission for recurrent stroke in obese stroke patients. Int J Stroke 2015;10:99-104.
128. Wohlfahrt P, Lopez-Jimenez F, Krajcoviechova A, Jozifova M, Mayer O, Vanek J, Filipovsky J, Llano EM, Cifkova R. The obesity paradox and survivors of ischemic stroke. J Stroke Cerebrovasc Dis 2015;24:1443-1450.
129. Zafrir B, Adir Y, Shehadeh W, Shteinberg M, Salman N, Amir O. The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the "obesity paradox". Respir Med 2013;107:139-146.